Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Operating Income: 2011-2012

Historic Operating Income for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -$6.5 million.

  • Sonoma Pharmaceuticals' Operating Income rose 71.11% to -$680,000 in Q4 2012 from the same period last year, while for Dec 2012 it was -$3.5 million, marking a year-over-year increase of 45.88%. This contributed to the annual value of -$6.5 million for FY2012, which is 13.83% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Operating Income stood at -$6.5 million for FY2012, which was up 13.83% from -$7.5 million recorded in FY2011.
  • Over the past 5 years, Sonoma Pharmaceuticals' Operating Income peaked at -$6.5 million during FY2012, and registered a low of -$7.5 million during FY2011.
  • Its 2-year average for Operating Income is -$7.0 million, with a median of -$7.0 million in 2011.
  • Data for Sonoma Pharmaceuticals' Operating Income shows a peak YoY grew of 13.83% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Sonoma Pharmaceuticals' Operating Income stood at -$7.5 million in 2011, then grew by 13.83% to -$6.5 million in 2012.